Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patients in Sohag University Hospital

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age30+
SponsorSohag University

About this trial

The goal of this observational study is to investigate the potential association between MMP-9 gene polymorphism and susceptibility to Primary Open Angle Glaucoma development in Egyptian patients The main question it aims to

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Men and women older than 30 years

Primary open angle glaucoma as evidenced from characteristic visual field loss and optic disc cupping (POAG group)

Healthy subjects matched by age, sex and ethnicity to the POAG patients group (control group)

Disqualifiers

Exfoliation glaucoma, pigmentary glaucoma

History of acute angle closure

Trial population

Patients with Primary Open Angle Glaucoma in Department of ophthalmology in Sohag University Hospitals and healthy controls of matched age and sex

Trial design

Design model

Case-control

Time perspective

Cross-sectional

Treatments tested in this trial

  • genotyping assay by polymerase chain reaction

    Genetic

    Blood sample will be obtained from all participants by withdrawing 3 mL of blood via venipuncture in ethylenediaminetetraacetic acid tube. Thereafter, DNA extraction will be obtained after centrifugation to be used for genotyping assay of MMP-9 gene with polymerase chain reaction

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: Control Group1 intervention
Group B: Experimental Group1 intervention

Trial outcomes

Primary outcomes

1

Matrix metalloproteinase-9 gene polymorphism

Matrix metalloproteinase-9 gene polymorphism by polymerase chain reaction

Time frame
14 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: